Pure Global

Drug Eluting Coronary Stent System - India CDSCO Medical Device Registration

Drug Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000728_6a11d97158630de4cf3efb410f3c818b_dbea1e2a7b9ac928f7ea8e08aa35cb25. This device is marketed under the brand name BioMatrix Alpha. The license holder is Curis Healthcare, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Drug Eluting Coronary Stent System
UID: IMP/MD/2021/000728_6a11d97158630de4cf3efb410f3c818b_dbea1e2a7b9ac928f7ea8e08aa35cb25

Brand Name

BioMatrix Alpha

License Holder

Curis Healthcare

Device Class

Class D

Approving Authority

CDSCO

Product Information

The BioMatrix NeoFlex DES is indicated for improving coronary luminal diameter for the treatment of de novo lesions in native coronary arteries with a reference diameter ranging between 2.25 mm and 4.0 mm. Stents with length 33 mm and 36 mm are only available for artery diameters ranging between 2.5 mm and 3.5 mm. The BioMatrix NeoFlex DES with stent length up to 28 mm is also indicated for use in patients with: โ€ข ST elevated myocardial infarction (BioMatrix Alpha) โ€ข Acute Coronary Syndromes (BioMatrix Alpha) including ACS-STEMI, ACS-NSTEMI and Unstable Angina โ€ข Diabetes Mellitus

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from Curis Healthcare
Products from the same license holder (2 products)